Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

VENETOCLAX for B-cell lymphoma refractory: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 26 adverse event reports in the FDA FAERS database where VENETOCLAX was used for B-cell lymphoma refractory.

Most Reported Side Effects for VENETOCLAX

Side Effect Reports % Deaths Hosp.
Death 9,412 17.5% 9,399 774
Off label use 6,252 11.6% 2,257 1,642
Neutropenia 3,041 5.7% 626 1,121
Febrile neutropenia 2,663 5.0% 665 1,725
Platelet count decreased 2,367 4.4% 311 1,357
Pyrexia 2,351 4.4% 487 1,834
Pneumonia 2,300 4.3% 790 1,683
Fatigue 2,281 4.3% 168 920
Diarrhoea 2,082 3.9% 278 964
White blood cell count decreased 1,913 3.6% 198 1,007
Myelosuppression 1,864 3.5% 84 756
Thrombocytopenia 1,834 3.4% 404 653
Nausea 1,814 3.4% 197 772
Infection 1,757 3.3% 460 912
Anaemia 1,671 3.1% 329 712

Other Indications for VENETOCLAX

Acute myeloid leukaemia (19,774) Chronic lymphocytic leukaemia (14,194) Product used for unknown indication (4,628) Myelodysplastic syndrome (2,508) Plasma cell myeloma (1,778) Mantle cell lymphoma (1,367) Diffuse large b-cell lymphoma (761) Acute myeloid leukaemia recurrent (558) B-cell small lymphocytic lymphoma (499) Non-hodgkin's lymphoma (485)

Other Drugs Used for B-cell lymphoma refractory

RITUXIMAB (103) OBINUTUZUMAB (84) CISPLATIN (53) ETOPOSIDE (49) DEXAMETHASONE (45) AXICABTAGENE CILOLEUCEL (44) CYCLOPHOSPHAMIDE (43) CYTARABINE (40) IBRUTINIB (39) LENALIDOMIDE (36)

Related Pages

VENETOCLAX Full Profile All B-cell lymphoma refractory Drugs VENETOCLAX Demographics VENETOCLAX Timeline